NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
What is the latest Profit Before Tax of NATCO PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹2,291 Cr |
| Mar2024 | ₹1,674 Cr |
| Mar2023 | ₹862 Cr |
| Mar2022 | ₹202 Cr |
| Mar2021 | ₹580 Cr |
How is Profit Before Tax of NATCO PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,291 Cr | 36.92 | |
| Mar2024 | ₹1,674 Cr | 94.16 | |
| Mar2023 | ₹862 Cr | 326.26 | |
| Mar2022 | ₹202 Cr | -65.11 | |
| Mar2021 | ₹580 Cr | - | |
Compare Profit Before Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹21,450.8 Cr | -0.9% | 9.7% | 44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.9% |
9.7% |
44.3% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses